Pharma and Healthcare: Q1FY26: Steady Revenues, Margins Under Pressure
he India Pharma and Healthcare sector is expected to see steady revenue growth. However, EBITDA margins are expected to show a decline for Q1FY26E
224 Views
Torrent Pharmaceuticals (TRP IN): India Business Drives 11% PAT Growth in Q4; Margin Levers at Work
âTorrent Pharmaceuticals reported strong Q4FY25 results with an 11% YoY increase in net profit and 8% YoY revenue growth driven by domestic...
517 Views
APAC Healthcare Weekly (May 25)- 3SBio, Samsung Biologics, Celltrion, CSPC Pharma, Chugai
APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...
663 Views
Pharmaceuticals: US to cut Rx drug price, no impact on generics
The US president Donald Trump signed an âExecutive Orderâ (EO) to bring the prices for prescription (Rx) drugs in line with other developed nations
163 Views
Pharmaceuticals: Pharma dodges first round of US tariff risk
The US government under Trump 2.0 has announced reciprocal tariffs across countries, including ~26% tariff on imports from India
213 Views